iShares MSCI Taiwan ETF vs Guardant Health Inc. Common Stock — how do they compare? iShares MSCI Taiwan ETF trades at $114.13 (market cap $12.74B), while Guardant Health Inc. Common Stock trades at $166.91 (market cap $22.22B). The key difference: Guardant Health Inc. Common Stock is the larger of the two by market cap, and iShares MSCI Taiwan ETF is more actively traded (8,470,920 versus 1,589,453). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Taiwan ETF for 52 Days and Guardant Health Inc. Common Stock for 0 Days on average.
| EWT | GH | |
|---|---|---|
Market Cap | $12.74B | $22.22B |
Volume | 8,470,920 | 1,589,453 |
Sector | Broad Market / Factor | Health |
52-Week High | $118.00 | $187.22 |
52-Week Low | $60.03 | $61.73 |
Typical Hold Time | 52 Days | 0 Days |
Enterprise Value | — | $22.86B |
Signals from Pluang's Aura AI — not financial advice
EWT trades at $114.01, down 1.92% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF maintains strong exposure to Taiwan's semiconductor sector, particularly TSMC, which represents 22.5% of its portfolio. Recent news highlights Taiwan's strategic importance in AI chip manufacturing and ongoing US-Taiwan economic cooperation, with Taiwanese companies planning $20 billion in US investments driven by AI demand (Reuters, 2026-09-02).
The outlook remains positive given Taiwan's central role in AI semiconductor supply chains, though geopolitical tensions with China present significant risks. Analyst sentiment is generally bullish with institutional investors increasing positions, including Bank of America's 22.4% stake increase in Q2 2026. Key support levels at $110-$112 provide downside protection while resistance sits at $115-$117.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →